Ann Neurol

1. VAN DUIJVENBODEN S, Ramirez J, Scheurink J, Darweesh SKL, et al
   Heart Rate Profiles During Exercise and Incident Parkinson's Disease.
   Ann Neurol. 2025 Aug 2. doi: 10.1002/ana.70010.
   

   >> Share

   
   

   
   Exp Neurol

2. MIN X, Du Z, Wei J, Yuan Z, et al
   Pyridoxal phosphate inhibits alpha-synuclein-induced ferroptosis by activating GOT1 to enhance the methionine salvage pathway in Parkinson's disease.
   Exp Neurol. 2025;393:115411.
   

   >> Share

   
   

   
   Mov Disord

3. KRAUSS J, Upadhyay N, Purrer V, Borger V, et al
   Probabilistic Mapping of Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) Thalamotomy Targets in Essential Tremor and Tremor-Dominant Parkinson's Disease: Insights from a German Cohort.
   Mov Disord. 2025 Aug 8. doi: 10.1002/mds.70003.
   

   >> Share

   
   
4. ZARKALI A, Thomas G, Paterson R, Hannaway N, et al
   Impaired Glymphatic Clearance, Measured Using Diffusion Tensor Image Analysis Along the Perivascular Space (DTI-ALPS), is Linked to Poor Cognitive Outcomes in Parkinson's Disease.
   Mov Disord. 2025 Aug 7. doi: 10.1002/mds.30325.
   

   >> Share

   
   

   
   Nat Neurosci

5. MARUTANI E, Miranda M, Durham TJ, Kim SH, et al
   Hypoxia ameliorates neurodegeneration and movement disorder in a mouse model of Parkinson's disease.
   Nat Neurosci. 2025 Aug 6. doi: 10.1038/s41593-025-02010.
   

   >> Share

   
   

   
   Neurologia (Engl Ed)

6. ZHANG Y, Lin Y, Zhong CCW, Ho FF, et al
   Methodological quality of systematic reviews on treatments for Parkinson's disease: A cross-sectional study.
   Neurologia (Engl Ed). 2025;40:507-517.
   

   >> Share

   
   

   
   Neurology

7. GONZALEZ-ESCAMILLA G, Groppa S
   MRI-Based Evidence of Regular Physical Activity's Impact on Brain Networks for Modifying Disease Courses in Parkinson Disease.
   Neurology. 2025;105:e214059.
   

   >> Share

   
   
8. DIAZ-GALVAN P, Franco-Rosado P, Silva-Rodriguez J, Castro-Labrador S, et al
   Association of Physical Exercise With Structural Brain Changes and Cognitive Decline in Patients With Early Parkinson Disease.
   Neurology. 2025;105:e213932.
   

   >> Share

   
   

   
   Neurosci Lett

9. WANG J, Hou J, Du M, Hou X, et al
   The mechanism of alpha-lipoic acid regulating dopaminergic neuronal damage in Parkinson's disease through the Nrf2/HMOX1 pathway.
   Neurosci Lett. 2025 Aug 3:138338. doi: 10.1016/j.neulet.2025.138338.
   

   >> Share

   
   

   
   PLoS One

10. WANG H, Feng L, He L, Liu N, et al
    Bioinformatics analysis to explore biomarkers and mechanisms of action associated with endoplasmic reticulum stress and ferroptosis in Parkinson's disease.
    PLoS One. 2025;20:e0328682.
    

    >> Share

    
    
11. POLINSKI NK, Puolivali J, Rauhala L, Stenius TK, et al
    Expression of human A53T alpha-synuclein without endogenous rat alpha-synuclein fails to elicit Parkinson's disease-related phenotypes in a novel humanized rat model.
    PLoS One. 2025;20:e0329823.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

12. FERGUSON SM
    Derailed degradation: LRRK2-dependent exocytosis in Parkinson's disease.
    Proc Natl Acad Sci U S A. 2025;122:e2515758122.
    

    >> Share

    
    

    
    Rev Neurol

13. GARCIA-AGUA SOLER N, Garcia Trujillo L, Garcia-Ruiz AJ
    Cost of Quality of Life in Advanced Parkinson's Disease: Efficient Strategies for Disease Assessment.
    Rev Neurol. 2025;80:33482.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share